株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国の喘息治療薬市場

Asthma Treatment Drugs Markets in China

発行 Asia Market Information & Development 商品コード 91218
出版日 ページ情報 英文 285 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
中国の喘息治療薬市場 Asthma Treatment Drugs Markets in China
出版日: 2016年03月18日 ページ情報: 英文 285 Pages
概要

当報告書では、中国の経済動向、喘息治療薬市場の投資環境、産業の発展、需要および供給、産業構造、市場チャネルおよび主要企業などについて詳細に調査し、過去の実績や長期予測を提示し、概略以下の構成でお届けします。

第1章 イントロダクション

  • 本調査書の範囲と方法論
  • エグゼクティブサマリー

第2章 ビジネス環境

  • 経済展望
    • 主な経済指標
    • 工業生産量
    • 人口および労働力
    • 海外からの投資
    • 海外貿易
  • 金融および税金の規制
    • 銀行制度および規制
    • 外国為替
    • 税金、関税および税関

第3章 喘息治療薬産業の評価

  • 産業構造
  • 市場規模
  • 市場成長促進要因
  • 産業のキャパシティ
  • 主なメーカーの設備拠点および生産量
  • 主なメーカー設備拠点、生産量、市場シェア
    • グルココルチコイド薬
    • β2受容体作動薬
    • 抗コリン薬
    • ロイコトリエン受容体拮抗薬
    • テオフィリン
    • 抗アレルギー薬
    • その他の喘息治療薬
  • 労働コスト
  • 潜在性のある参入企業
  • 主な流通業者
  • 主な海外からの投資
  • 技術開発

第4章 喘息治療薬の生産および需要

  • 概要
  • 分類、需要、生産量および市場シェア
  • 生産量および需要
    • グルココルチコイド薬
    • β2受容体作動薬
    • ロイコトリエン受容体拮抗薬
    • 抗コリン薬
    • テオフィリン
    • 抗アレルギー薬
    • その他の喘息治療薬
  • 輸出入

第5章 喘息治療薬市場の展望

  • 喘息治療薬市場の展望
    • グルココルチコイド薬の展望
    • β2受容体作動薬の展望
    • ロイコトリエン受容体拮抗薬の展望
    • 抗コリン薬の展望
    • テオフィリンの展望
    • 抗アレルギー薬の展望

第6章 マーケティング戦略

  • 中国市場参入の概要
    • 中国流通システム
    • 喘息治療薬の流通チャネル
    • 運輸および輸送インフラ
    • 通信
  • 中国市場参入
    • ライセンス
    • フランチャイズ
    • Eコマース
    • 貿易会社と現地代理店
    • 代表事務所と中国子会社
    • 完全外資企業

第7章 喘息治療薬メーカーのディレクトリー

  • メーカーのプロファイル

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 803

China's demand for Asthma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. ASTHMA TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Asthma Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Asthma Treatment Drugs Industry Capacity Output
  • Major Producer Facility Locations and Output
  • Major Glucocorticoid Drugs Producer Facility Locations, Output and Market Share
  • Major β2 Receptor Agonists Producer Facility Locations, Output and Market Share
  • Major Anticholinergic Drugs Producer Facility Locations, Output and Market Share
  • Major Leukotriene Receptor Antagonist Producer Facility Locations, Output and Market Share
  • Major Theophylline Producer Facility Locations, Output and Market Share
  • Major Antiallergic Agent Producer Facility Locations and Output
  • Major Other Asthma Treatment Drugs Producer Facility Locations and Output
  • Labor Cost
  • Potential Entrants
  • Major Distributor
  • Major Foreign Investments
  • Technology Development

IV. ASTHMA TREATMENT DRUGS OUTPUT AND DEMAND

  • Overview
  • Asthma Treatment Drugs Classification, Demand, Output and Share
  • Asthma Treatment Drugs Output and Demand
  • Glucocorticoid Drugs
  • β2 Receptor Agonists
  • Leukotriene Receptor Antagonist
  • Anticholinergic Drugs
  • Theophylline
  • Antiallergic Agent
  • Other Asthma Treatment Drugs
  • Asthma Treatment Drugs Imports and Exports
  • Asthma Treatment Drugs Imports
  • Asthma Treatment Drugs Exports

V. ASTHMA TREATMENT DRUGS MARKET OUTLOOK

  • Asthma Treatment Drugs Markets Outlook Overview
  • Glucocorticoid Drugs Outlook
  • β2 Receptor Agonists Industry Outlook
  • Leukotriene Receptor Antagonist Outlook
  • Anticholinergic Drugs Outlook
  • Theophylline Outlook
  • Antiallergic Agent Outlook

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Special Rubber Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprise

VII. ASTHMA TREATMENT DRUGS PRODUCER DIRECTORY

  • Asthma Treatment Drugs Producer Profiles

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary
  • Asthma Treatment Drugs Supply and Demand Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
  • Key Commodity Exports from China
  • China's Exports to its Leading Trade Partners
  • Key Commodity Imports into China
  • China's Imports from Its Leading Trade Partners

III. ASTHMA TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Asthma Treatment Drugs Industry Capacity by Classification
  • Asthma Treatment Industry Output by Classification
  • Major Asthma Treatment Drugs Producer Facility Location
  • Major Glucocorticoid Drugs Producer Facility Locations, Output and Market Share
  • Majorβ2 Receptor Agonists Producer Facility Locations, Output and Market Share
  • Major Leukotriene Receptor Antagonist Producer Facility Locations, Output and Market Share
  • Major Anticholinergic Drugs Producer Facility Locations, Output and Market Share
  • Major Theophylline Producer Facility Locations, Output and Market Share
  • Major Antiallergic Agent Producer Facility Locations, Output and Market
  • Major Other Asthma Treatment Drugs Facility Locations, Output and Market Share
  • Major Foreign Investment in China

IV. ASTHMA TREATMENT DRUGS OUTPUT AND DEMAND

  • Asthma Treatment Drugs Output and Demand
  • Asthma Treatment Drugs Classification, Output, Demand and Share
  • Glucocorticoid Drugs Capacity, Output, Import, Export and Demand
  • β2 Receptor Agonists Capacity, Output, Import, Export and Demand
  • Leukotriene Receptor Antagonist Capacity, Output, Import, Export and Demand
  • Anticholinergic Drugs Capacity, Output, Import, Export and Demand
  • Theophylline Drugs Capacity, Output, Import, Export and Demand
  • Antiallergic Agent Capacity, Output, Import, Export and Demand
  • Other Asthma Treatment Drugs Capacity, Output, Import, Export and Demand
  • China Asthma Treatment Drugs Imports and Exports

V. ASTHMA TREATMENT DRUGS MARKET OUTLOOK

  • Total Asthma Treatment Drugs Output and Demand by Market
  • Glucocorticoid Drugs Classification by Output and Share
  • Glucocorticoid Drugs Output Demand and Growth Rate
  • Major Glucocorticoid Drugs Producers' Locations
  • β2 Receptor Agonists Classification by Output and Share
  • β2 Receptor Agonists Output, Demand and Growth Rate
  • Majorβ2 Receptor Agonists Producer Facility Output and Locations
  • Leukotriene Receptor Antagonist Classification by Output and Market Share
  • Leukotriene Receptor Antagonist Output, Demand and Growth Rate
  • Major Leukotriene Receptor Antagonist Producers' Locations
  • Major Anticholinergic Drugs Producer Output and Locations
  • Theophylline Drugs Classification by and Market Share
  • Theophylline Drugs Output, Demand and Growth Rate
  • Major Theophylline Producers' Locations
  • Antiallergic Agent Classification by Output and Market Share
  • Antiallergic Agent Output Demand and Growth Rate
  • Major Antiallergic Agent Producers' Locations

LIST OF CHARTS

I. INTRODUCTION

  • Asthma Treatment Drugs Capacity, Output, Demand

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. ASTHMA TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Asthma Treatment Drugs Capacity in China
  • Asthma Treatment Drugs Output in China
  • Asthma Treatment Drugs Capacity, Output and Demand

IV. ASTHMA TREATMENT DRUGS OUTPUT AND DEMAND

  • Total Asthma Treatment Drugs Output and Demand
  • Asthma Treatment Drugs Classification and Output Share
  • Asthma Treatment Drugs Classification and Demand Share
  • Glucocorticoid Drugs Output
  • Glucocorticoid Drugs Demand
  • β2 Receptor Agonists Output
  • β2 Receptor Agonists Demand
  • Leukotriene Receptor Antagonist Output
  • Leukotriene Receptor Antagonist Demand
  • Anticholinergic Drugs Output
  • Anticholinergic Drugs Demand
  • Theophylline Output
  • Theophylline Demand
  • Antiallergic Agent Output
  • Antiallergic Agent Demand
  • Total Asthma Treatment Drugs Imports
  • Total Asthma Treatment Drugs Exports

V. ASTHMA TREATMENT DRUGS MARKET OUTLOOK

  • Asthma Treatment Drugs Classification and Output Share
  • Asthma Treatment Drugs Classification and Demand Share
  • Glucocorticoid Drugs Output and Growth Rate
  • Glucocorticoid Drugs Demand and Growth Rate
  • β2 Receptor Agonists Demand and Growth Rate
  • Leukotriene Receptor Antagonist Output and Growth Rate
  • Leukotriene Receptor Antagonist Demand and Growth Rate
  • Anticholinergic Drugs Output and Growth Rate
  • Anticholinergic Drugs Demand and Growth Rate
  • Theophylline Output and Growth Rate
  • Theophylline Demand and Growth Rate
  • Antiallergic Agent Output and Growth Rate
  • Antiallergic Agent Demand and Growth Rate

VI. MARKETING STRATEGIES

  • China's Distribution Channel
Back to Top